CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Moore David Scott Director | Purchase | +21,700 | $11.53 | $250K | 21,700 |
| 2026-06-11 | Moore David Scott Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-11 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-11 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-11 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-11 | van den Broek Richard Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-05-18 | MILLER RICHARD A MD President and CEO | Purchase | +5,000 | $12.05 | $60K | 1,193,103 |
| 2026-05-18 | MILLER RICHARD A MD President and CEO | Purchase | +1,932 | $12.01 | $23K | 1,195,035 |
| 2026-04-23 | Chan Andrew C. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +30,000 | $15.00 | $450K | 30,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $9.70 | $146K | 45,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $12.50 | $188K | 60,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $3.61 | $54K | 75,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.00 | $30K | 90,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $3.27 | $49K | 105,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.74 | $41K | 120,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.60 | $39K | 135,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $0.99 | $15K | 150,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $0.97 | $14K | 165,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.49 | $37K | 180,000 |
Page 1 of 15 · 282 trades